Align Wealth Management’s iShares US Medical Devices ETF IHI Stock Holding History

Align Wealth Management’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$708	Buy	+15	New	+$761	﹤0.01%	197

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Align Wealth Management's IHI Position: Q4 2022 in Review

Align Wealth Management opened a new position in iShares US Medical Devices ETF (IHI) in Q4 2022: 15 shares worth $708. The stake represents ﹤0.01% of the portfolio and ranks #197 among its holdings.

577 funds tracked by Wall St. Rank hold IHI as of Q4 2022.

Align Wealth Management held 15 shares of iShares US Medical Devices ETF worth $708 as of Q4 2022.
iShares US Medical Devices ETF was a new Align Wealth Management position in Q4 2022.
iShares US Medical Devices ETF made up ﹤0.01% of Align Wealth Management's portfolio in Q4 2022, its #197 holding.
577 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2022.

Based on Align Wealth Management's 13F filing for Q4 2022, filed 9 Jan 2023.